AEBI LTD has a total of 11 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOGAM INST FOR BIOMEDICAL RES, I2 PHARMACEUTICALS INC and GLYCONEX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Combinatorial chemistry | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Morad Ilan | 10 |
#2 | Itzhaki Hanan | 9 |
Publication | Filing date | Title |
---|---|---|
US2020339629A1 | Therapeutic constructs comprising cmet binding peptides | |
WO2019064297A1 | Cytotoxic peptides and conjugates thereof | |
US2019225711A1 | Therapeutic multi-targeting constructs and uses thereof | |
IL188908D0 | Recombinant bacteriophage peptide library and its use for identifying a peptide or a polypeptide which has an intermolecular interaction with a target of interest | |
EP1915617A2 | Methods and compositions for identifying a peptide having an intermolecular interaction with a target of interest |